Are all seborrheic keratoses benign? Review of the typical lesion and its variants

Journal of Cutaneous Medicine and Surgery

Volumn 12, Issue 5, 2008, Pages 203-210

  Noiles, Kristin ^a,b   Vender, Ronald ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE; FIBROBLAST GROWTH FACTOR RECEPTOR 3; IMIQUIMOD; PROTEIN BCL 2; PROTEIN P16; TAZAROTENE; VIRUS DNA;

ACANTHOMA; ACANTHOSIS NIGRICANS; BASAL CELL CARCINOMA; BOWEN DISEASE; CONDYLOMA ACUMINATUM; CREAM; CRYOTHERAPY; DARIER DISEASE; DERMATOSIS PAPULOSA NIGRA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FIBROMA; HUMAN; KERATOSIS; LARGE CELL ACANTHOMA; LICHENOID; LICHENOID KERATOSIS; LOW LEVEL LASER THERAPY; MALIGNANT LENTIGO; MELANOCYTIC NEVUS; MELANOMA; NEVUS; PAPILLOMATOSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEBORRHEIC KERATOSIS; SKIN DISEASE; SKIN SURGERY; SQUAMOUS CELL CARCINOMA; STUCCO KERATOSIS; VERRUCA VULGARIS; WART VIRUS; CLASSIFICATION; PATHOLOGY; SKIN TUMOR;

HUMANS; KERATOSIS, SEBORRHEIC; SKIN NEOPLASMS;

EID: 58849092457     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2008.07096     Document Type: Review

References (47)

1. Requena L, Kutzner H. Seborrheic keratosis with pseudorosettes and adamantinoid seborrheic keratosis: two new histopathologic variants. J Cutan Pathol 2006;33:42-5.
2. Hafner C, Hartmann A, Real FX, et al. Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. J Invest Dermatol 2007;127:1883-5.
3. Kwon OS, Hwang EJ, Bae JH, et al. Seborrheic keratosis in the Korean males: causative role of sunlight. Photodermatol Photoimmunol Photomed 2003;19:73-80.
4. Pierson D, Bandel C, Ehrig T, et al. Benign epidermal tumors and proliferations. In: Bologna JL, Jorizzo JL, Raphini RP, et al, editors. Dermatology. Vol 2. Toronto: Mosby; 2000. p. 1697-717.
5. Cascajo CD, Reichel M, Sánchez JL. Malignant neoplasms associated with seborrheic keratoses: an analysis of 54 cases. Am J Dermatopathol 1996;18:278-82.
6. Nakamura S, Nishioka K. Enhanced expression of p16 in seborrheic keratosis; a lesion of accumulated senescent epidermal cells in G1 arrest. Br J Dermatol 2003;149:560.
7. Hafner C, Hartmann A, van Oers JMM, et al. FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization. Mod Pathol 2007;20:895-903.
8. Logie A, Dunois-Larde C, Rosty C, et al. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Hum Mol Genet 2005;14:1153-60.
9. Hafner C, van Oers JMM, Hartmann A, et al. High frequency of FGFR3 mutations in adenoid seborrheic keratoses. J Invest Dermatol 2006;126:2404-7.
10. L'Hote CG, Knowles MA. Cell responses to FGFR3 signalling: growth, differentiation and apoptosis. Exp Cell Res 2005;304:417-31.
11. Hafner C, López-Knowles E, Luis NM, et al. Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc Natl Acad Sci U S A 2007; 104:13450-4.
12. Rongioletti F, Corbella L, Rebora A. Multiple familial seborrheic keratoses. Dermatologica 1988;176:43-5.
13. Ihm CW. Squamous eddies in irritated seborrheic keratosis. Am J Dermatopathol 2007;29:28-31.
14. Nakamura H, Hirota S, Adachi S, et al. Clonal nature of seborrheic keratosis demonstrated by using the polymorphism of the human androgen receptor locus as a marker. J Invest Dermatol 2001;116: 506-10.
15. Li J, Ackerman AB. "Seborrheic keratoses" that contain human papillomavirus are condyloma acuminata. Am J Dermatopathol 1994;16:398-405.
16. Gushi A, Kanekura T, Kanzaki T, et al. Detection and sequences of human papillomavirus DNA in nongenital seborrheic keratosis of immunopotent individuals. J Dermatol Sci 2003;31:143-9.
17. Li Y-H, Chen G, Dong X-P, et al. Detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in nongenital seborrheic keratosis. Br J Dermatol 2004;151:1060-5.
18. Stockfleth E, Rowert J, Arndt R, et al. Detection of human papillomavirus and response to topical 5% imiquimod in a case of stucco keratosis. Br J Dermatol 2000;143:846-50.
19. Braun RP, Rabinovitz HS, Krischer J, et al. Dermoscopy of pigmented seborrheic keratosis. Arch Dermatol 2002;138:1556-60.
20. Schwartzberg JB, Ricotti CA, Ballard CJ, et al. Eruptive dermatosis papulosa nigra as a possible sign of internal malignancy. Int J Dermatol 2007;46:186-7.
21. Grimes PE, Arora S, Minus HR, et al. Dermatosis papulosa nigra. Cutis 1983;32:385-6.
22. Shall L, Marks R. Stucco karatoses. A clinico-pathological study. Acta Derm Venereol 1991;71:258-61.
23. Astori G, Lavergne D, Benton C, et al. Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 1998;110:725-52.
24. Adrian JC. Inverted follicular keratosis of the lip. Oral Surg Oral Med Oral Pathol 1984;57:625-30.
25. Shih CC, Yu HS, Tung YC, et al. Inverted follicular keratosis. Kaohsiung J Med Sci 2000;17:50-4.
26. Cakmak SS, Unhi MK, Bilek B, et al. Conjunctival inverted follicular keratosis: a case report. Jpn J Ophthalmol 2004;48:497-8.
27. Ruboy SM, Thomas D, Nuovo GJ. Multiple inverted follicular keratoses as a presenting sign of Cowden's syndrome: case report with human papillomavirus studies. J Am Acad Dermatol 2004;51: 411-5.
28. Mehregan DR, Hamzavi F, Brown K. Large cell acanthoma. Am J Dermatopathol 1994;16:140-4.
29. Chévez P, Patrinelv JR, Font RL. Large-cell acanthoma of the eyelid. Report of two cases. Arch Ophthamol 1991;109:1433-4.
30. Ackerman AB, Maize JC. Circumscribed hyperpigmentation without apparent proliferation of melanocytes. In: Pigmented lesions of the skin. Philadelphia: Lea & Febiger; 1987. p. 56-9.
31. Roewart HJ, Ackerman AB. Large-cell acanthoma is a solar lentgo. Am J Dermatopathol 1992;14:122-32.
32. Sánchez YE, del Rio E, Requena L. Large-cell acanthoma is a distinctive condition. Am J Dermatopathol 1992;14:140-7.
33. Zaballos P, Blazquez S, Puig S. Dermoscopic pattern of intermediate stage in seborrheic keratosis regressing to lichenoid keratosis: report of 24 cases. Br J Dermatol 2007;157: 266-72.
34. Izikson L, Sober AJ, Mihm MC, et al. Prevalence of melanoma clinically resembling seborrheic keratosis. Arch Dermatol 2002;138: 1562-6.
35. Pelin K, Bengu NA, Etem A, et al. Post-renal transplantation Leser-Trélat sign associated with carcinoma of the gallbladder: a rare association. Scand J Gastroenterol 2007;42:779-81.
36. Heaphy MR, Millns JL, Schroeter AL. The sign of Leser-Trélat in a case of adenocarcinoma of the lung. J Am Acad Dermatol 2000;43: 386-90.
37. Flugman SL, McClain SA, Clark RA. Transient eruptive seborrheic keratoses associated with erythrodermic psoriasis and erythdodermic drug eruption: report of 2 cases. J Am Acad Dermatol 2001; 45(6 Suppl):212-4.
38. Garcia R, Bishop M. The rapid onset of seborrheic keratosis of the breast during pregnancy. J Assoc Mil Dermatol 1977;3:13-4.
39. Chu CY, Yang CH, Chiu HC. Inflammation of seborrheic keratoses due to docetaxel treatment. Acta Derm Venereol 2001; 81:316-7.
40. Patton T, Zirwas M, Nieland-Fisher N, et al. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trélat. J Drugs Dermatol 2004;3:565-6.
41. Williams JV, Helm KF, Long D. Chemotherapy-induced inflammation in seborrheic keratosis mimicking disseminated herpes zoster. J Am Acad Dermatol 1999;40:643-4.
42. Lim C. Seborrheic keratoses with associated lesions: a retrospective analysis of 85 lesions. Am J Dermatol 2006;47:109-15.
43. Sowden JM, Lewis-Jones MS, Williams RB. The management of seborrheic keratoses by general practitioners, surgeons and dermatologists. Br J Dermatol 1998;139:348-9.
44. Mehrabi D, Brodell RT. Use of the alexandrite laser for treatment of seborrheic keratoses. Dermatol Surg 2002;28:437-9.
45. Herron MD, Bowen AR, Krueger GG. Seborrheic keratoses: a study comparing the standard cryosurgery with topical calcipotriene, topical tazarotene, and topical imiquimod. Int J Dermatol 2004;43: 300-2.
46. Mandekou-Lefaki I, Delli F, Teknetzis A, et al. Successful treatment of seborrheic keratosis with imiquimod 5% cream. Int J Immunother 2004;20:23-8.
47. Burkhart CG. The search for topical treatments for seborrheic keratoses continues. Int J Dermatol 2006;45:1110.